Atrion Corp (ATRI)

$457.65

Market is closed - opens 7 PM, 29 Jul 2024

Performance

  • $457.60
    $458.01
    $457.65
    downward going graph

    0.01%

    Downside

    Day's Volatility :0.09%

    Upside

    0.08%

    downward going graph
  • $266.67
    $553.80
    $457.65
    downward going graph

    41.73%

    Downside

    52 Weeks Volatility :51.85%

    Upside

    17.36%

    downward going graph

Returns

PeriodAtrion CorpSector (Health Care)Index (Russel 2000)
3 Months
15.86%
6.5%
0.0%
6 Months
43.02%
7.1%
0.0%
1 Year
-16.78%
9.8%
0.0%
3 Years
-25.25%
14.2%
-20.2%

Highlights

Market Capitalization
806.3M
Book Value
$137.46
Dividend Share
8.75
Dividend Yield
1.92%
Earnings Per Share (EPS)
10.62
PE Ratio
43.14
PEG Ratio
0.0
Wall Street Target Price
300.0
Profit Margin
10.6%
Operating Margin TTM
11.5%
Return On Assets TTM
5.66%
Return On Equity TTM
7.79%
Revenue TTM
176.7M
Revenue Per Share TTM
100.35
Quarterly Revenue Growth YOY
18.4%
Gross Profit TTM
75.9M
EBITDA
39.1M
Diluted Eps TTM
10.62
Quarterly Earnings Growth YOY
-0.2
EPS Estimate Current Year
0.0
EPS Estimate Next Year
0.0
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Buy
    100%Buy
    0
    0%Hold
    0
    0%Sell
Based on 1 Wall street analysts offering stock ratings for Atrion Corp(by analysts ranked 0 to 5 stars)
Based on 1 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
1
00
00
Hold
00
2
2
Sell
00
4
4

Analyst Forecast

What analysts predicted

Downside of 34.45%

Current $457.65
Target $300.00

Company Financials

FY18Y/Y Change
Revenue
152.4M
↑ 3.99%
Net Income
34.3M
↓ 6.39%
Net Profit Margin
22.47%
↓ 2.49%
FY19Y/Y Change
Revenue
155.1M
↑ 1.72%
Net Income
36.8M
↑ 7.32%
Net Profit Margin
23.71%
↑ 1.24%
FY20Y/Y Change
Revenue
147.6M
↓ 4.82%
Net Income
32.1M
↓ 12.64%
Net Profit Margin
21.76%
↓ 1.95%
FY21Y/Y Change
Revenue
165.0M
↑ 11.8%
Net Income
33.1M
↑ 2.93%
Net Profit Margin
20.03%
↓ 1.73%
FY22Y/Y Change
Revenue
183.5M
↑ 11.21%
Net Income
35.0M
↑ 5.91%
Net Profit Margin
19.08%
↓ 0.95%
FY23Y/Y Change
Revenue
169.3M
↓ 7.73%
Net Income
19.4M
↓ 44.55%
Net Profit Margin
11.46%
↓ 7.62%
Q4 FY22Q/Q Change
Revenue
42.9M
↓ 3.98%
Net Income
8.3M
↓ 5.85%
Net Profit Margin
19.42%
↓ 0.38%
Q1 FY23Q/Q Change
Revenue
40.0M
↓ 6.68%
Net Income
3.5M
↓ 58.12%
Net Profit Margin
8.71%
↓ 10.71%
Q2 FY23Q/Q Change
Revenue
43.8M
↑ 9.61%
Net Income
6.6M
↑ 88.32%
Net Profit Margin
14.97%
↑ 6.26%
Q3 FY23Q/Q Change
Revenue
41.9M
↓ 4.4%
Net Income
2.9M
↓ 55.22%
Net Profit Margin
7.01%
↓ 7.96%
Q4 FY23Q/Q Change
Revenue
43.6M
↑ 3.99%
Net Income
6.4M
↑ 118.58%
Net Profit Margin
14.74%
↑ 7.73%
Q1 FY24Q/Q Change
Revenue
47.3M
↑ 8.6%
Net Income
2.8M
↓ 56.54%
Net Profit Margin
5.9%
↓ 8.84%
FY18Y/Y Change
Total Assets
231.2M
↑ 13.46%
Total Liabilities
20.4M
↑ 5.45%
FY19Y/Y Change
Total Assets
262.0M
↑ 13.33%
Total Liabilities
24.2M
↑ 18.15%
FY20Y/Y Change
Total Assets
266.9M
↑ 1.85%
Total Liabilities
26.4M
↑ 9.47%
FY21Y/Y Change
Total Assets
267.3M
↑ 0.14%
Total Liabilities
23.0M
↓ 13.16%
FY22Y/Y Change
Total Assets
264.7M
↓ 0.95%
Total Liabilities
25.2M
↑ 9.59%
FY23Y/Y Change
Total Assets
260.8M
↓ 1.47%
Total Liabilities
17.9M
↓ 28.74%
Q4 FY22Q/Q Change
Total Assets
264.7M
↓ 2.66%
Total Liabilities
25.2M
↓ 1.98%
Q1 FY23Q/Q Change
Total Assets
261.4M
↓ 1.24%
Total Liabilities
22.8M
↓ 9.47%
Q2 FY23Q/Q Change
Total Assets
266.8M
↑ 2.06%
Total Liabilities
25.9M
↑ 13.7%
Q3 FY23Q/Q Change
Total Assets
264.8M
↓ 0.76%
Total Liabilities
24.6M
↓ 4.95%
Q4 FY23Q/Q Change
Total Assets
260.8M
↓ 1.5%
Total Liabilities
17.9M
↓ 27.17%
Q1 FY24Q/Q Change
Total Assets
258.6M
↓ 0.84%
Total Liabilities
16.7M
↓ 6.87%
FY18Y/Y Change
Operating Cash Flow
43.2M
↓ 8.08%
Investing Cash Flow
-5.1M
↓ 75.65%
Financing Cash Flow
-9.5M
↓ 40.58%
FY19Y/Y Change
Operating Cash Flow
42.5M
↓ 1.78%
Investing Cash Flow
-44.8M
↑ 782.42%
Financing Cash Flow
-11.3M
↑ 18.83%
FY20Y/Y Change
Operating Cash Flow
39.2M
↓ 7.64%
Investing Cash Flow
-30.8M
↓ 31.23%
Financing Cash Flow
-31.0M
↑ 173.39%
FY21Y/Y Change
Operating Cash Flow
38.8M
↓ 1.08%
Investing Cash Flow
2.0M
↓ 106.47%
Financing Cash Flow
-31.0M
↓ 0.02%
FY22Y/Y Change
Operating Cash Flow
28.8M
↓ 25.8%
Investing Cash Flow
-15.3M
↓ 865.68%
Financing Cash Flow
-41.0M
↑ 32.47%
Q4 FY22Q/Q Change
Operating Cash Flow
-158.0K
↓ 101.49%
Investing Cash Flow
-5.1M
↓ 155.59%
Financing Cash Flow
-15.2M
↑ 66.4%
Q1 FY23Q/Q Change
Operating Cash Flow
4.3M
↓ 2839.24%
Investing Cash Flow
-77.0K
↓ 98.49%
Financing Cash Flow
-4.4M
↓ 70.84%
Q2 FY23Q/Q Change
Operating Cash Flow
-598.0K
↓ 113.82%
Investing Cash Flow
-2.6M
↑ 3322.08%
Financing Cash Flow
-1.0M
↓ 76.9%

Technicals Summary

Sell

Neutral

Buy

Atrion Corp is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Atrion Corp
Atrion Corp
1.04%
43.02%
-16.78%
-25.25%
-39.13%
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
-1.32%
16.54%
32.6%
35.62%
148.32%
Resmed Inc.
Resmed Inc.
11.69%
9.57%
-6.0%
-19.79%
64.22%
Becton, Dickinson And Company
Becton, Dickinson And Company
0.5%
-1.64%
-17.69%
-6.68%
-8.49%
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
-14.37%
-23.3%
-26.95%
-26.58%
102.44%
Alcon Ag
Alcon Ag
2.41%
20.84%
8.21%
30.7%
54.72%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Atrion Corp
Atrion Corp
43.14
43.14
0.0
0.0
0.08
0.06
0.02
137.46
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
78.14
78.14
7.13
6.63
0.16
0.08
NA
41.4
Resmed Inc.
Resmed Inc.
32.24
32.24
1.75
7.73
0.22
0.12
0.01
31.52
Becton, Dickinson And Company
Becton, Dickinson And Company
50.71
50.71
1.34
13.04
0.05
0.03
0.02
88.74
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
42.71
42.71
6.72
7.74
0.21
0.11
0.0
36.72
Alcon Ag
Alcon Ag
44.05
44.05
4.59
3.07
0.05
0.02
0.0
42.13
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Atrion Corp
Atrion Corp
Buy
$806.3M
-39.13%
43.14
10.6%
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
Buy
$161.3B
148.32%
78.14
27.65%
Resmed Inc.
Resmed Inc.
Buy
$30.8B
64.22%
32.24
20.91%
Becton, Dickinson And Company
Becton, Dickinson And Company
Buy
$68.6B
-8.49%
50.71
6.76%
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
Buy
$23.7B
102.44%
42.71
19.42%
Alcon Ag
Alcon Ag
Buy
$45.8B
54.72%
44.05
10.96%

Insights on Atrion Corp

  • Increasing Revenue

    Revenue is up for the last 3 quarters, 41.91M → 47.33M (in $), with an average increase of 5.9% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 6.42M → 2.79M (in $), with an average decrease of 56.5% per quarter

  • Vs ISRG

    In the last 1 year, Intuitive Surgical, Inc. has given 32.6% return, outperforming this stock by 49.4%

  • Vs ISRG

    In the last 3 years, Intuitive Surgical, Inc. has given 35.6% return, outperforming this stock by 60.8%

Institutional Holdings

  • Kayne Anderson Rudnick Investment Management LLC

    11.55%

  • Neuberger Berman Group LLC

    10.18%

  • T. Rowe Price Investment Management,Inc.

    7.88%

  • BlackRock Inc

    5.91%

  • Vanguard Group Inc

    4.82%

  • Morgan Stanley - Brokerage Accounts

    3.45%

Company Information

atrion corp is a medical device company located in 527 plymouth rd, plymouth, pennsylvania, united states.

Organization
Atrion Corp
Employees
712
CEO
Mr. Emile A. Battat
Industry
Health Technology

Discover More

FAQs